AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
InfuSystem Holdings, Inc.
XASE · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001SQTYK1
13.94▼ 0.20 (-1.41%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
14.14
Day's Range
13.78 – 14.11
52-Week Range
7.29 – 14.41
Volume
163.9K
Avg Volume
129.3K
Share Statistics
Shares Outstanding
Employees
473
Exchange
XASE
Listed
1992-12-22
Share count as of July 31, 2026

InfuSystem Holdings, Inc. (INFU) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about InfuSystem Holdings, Inc. (INFU)
What is InfuSystem Holdings, Inc.'s Market Cap?
InfuSystem Holdings, Inc.'s Market Cap is $277.6M, based on as-reported figures from SEC (XBRL) filings.
What is InfuSystem Holdings, Inc.'s Enterprise Value?
InfuSystem Holdings, Inc.'s Enterprise Value is $297.1M, based on as-reported figures from SEC (XBRL) filings.
What is InfuSystem Holdings, Inc.'s Trailing P/E?
InfuSystem Holdings, Inc.'s Trailing P/E is 32.5×, based on as-reported figures from SEC (XBRL) filings.
What is InfuSystem Holdings, Inc.'s Price / Sales?
InfuSystem Holdings, Inc.'s Price / Sales is 1.9×, based on as-reported figures from SEC (XBRL) filings.
What is InfuSystem Holdings, Inc.'s EV / Revenue?
InfuSystem Holdings, Inc.'s EV / Revenue is 2.1×, based on as-reported figures from SEC (XBRL) filings.
What is InfuSystem Holdings, Inc.'s EV / EBITDA?
InfuSystem Holdings, Inc.'s EV / EBITDA is 11.3×, based on as-reported figures from SEC (XBRL) filings.
What is InfuSystem Holdings, Inc.'s Revenue (TTM)?
InfuSystem Holdings, Inc.'s Revenue (TTM) is $143.3M, based on as-reported figures from SEC (XBRL) filings.
What is InfuSystem Holdings, Inc.'s Net Income (TTM)?
InfuSystem Holdings, Inc.'s Net Income (TTM) is $8.5M, based on as-reported figures from SEC (XBRL) filings.
What is InfuSystem Holdings, Inc.'s EBITDA?
InfuSystem Holdings, Inc.'s EBITDA is $26.3M, based on as-reported figures from SEC (XBRL) filings.
What is InfuSystem Holdings, Inc.'s Diluted EPS (TTM)?
InfuSystem Holdings, Inc.'s Diluted EPS (TTM) is 0.43, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · INFUAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Net revenues
YoY growth+2.6%-3.0%+7.0%+3.3%
Cost of revenues
Gross profit
% of revenue58.0%58.4%56.4%57.1%
Selling, general and administrative expenses:
Amortization of intangibles
Selling and marketing
General and administrative
Total selling, general and administrative
% of revenue46.7%53.7%46.2%46.6%
Operating income
% of revenue11.2%4.7%10.3%10.4%
Other expense:
Interest expense
Other (expense) income——
Income before income taxes
Provision for income taxes
Net income
% of revenue8.7%3.0%5.6%6.2%
Basic (in dollars per share)
Diluted (in dollars per share)